I have also noticed that some of these smaller issues have not shown much interest or have been pulled.
ie. ArcPac, Aconex, Citadel (it had insto interest but no retail)
The exception is Simonds but this is a larger ipo.
In saying that there are some positives
1. Hot healthcare sector
2. $15m earning from $96m revenue
3. 6yr EBITDA cagr 24%
4. Returns on invested capital >50%
5. Priced slightly cheaper than ONT but this stock hardly trades
22 - 24X FY15 (appears pricey)
I have found out Bells are co-leading but only one guy in Brisbane has access to the deal.
